Maharashtra FDA issues notices to Vimal ad endorsers over surrogate advertising concerns
Maharashtra’s FDA has issued notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff over Vimal Elaichi advertisements, examining whether they amount to surrogate promotion of prohibited Vimal Pan Masala. The action raises fresh compliance and reputational risk for the brand.
What happened
Maharashtra FDA issued notices to Ajay Devgn, Shah Rukh Khan and Tiger Shroff over Vimal Elaichi advertising, alleging possible surrogate promotion of
Key facts
- Rs 10 lakh
- one year
- 2012
- 13 July 2026
Why this matters
Any partnership, licensing or investment involving pan masala-adjacent brands now warrants deeper diligence on surrogate-marketing exposure, endorsement dependencies and regulatory contingencies.
What to watch
- Whether Maharashtra FDA converts notices into penalties, takedown orders or a formal finding of surrogate advertising.
- Responses from Shah Rukh Khan, Ajay Devgn, Tiger Shroff, their management teams and Vimal regarding campaign continuation.
- Any directive from the Ministry of Information and Broadcasting, ASCI, CCPA, FSSAI, state FDA bodies or broadcasters.
- Withdrawal, editing or replacement of Vimal Elaichi advertisements across television, digital, outdoor and cinema channels.
- Evidence that enforcement expands to other pan masala-linked brands or to publishers carrying the advertisements.
- Changes in Vimal media spending, celebrity contract renewals and campaign creative over the next two quarters.
- Vimal is likely to seek legal clarification, emphasize product-category separation and submit documentation on packaging, distribution and advertising approvals.
- The brand may temporarily reduce national celebrity-led ad frequency, especially around high-visibility sports, television and digital inventory.
- Advertising agencies and media owners may add enhanced legal review, indemnity clauses and product-category disclosures for pan masala-adjacent accounts.
- Competing pan masala and mouth-freshener brands may preemptively refresh creatives to remove cues linking legal FMCG products with tobacco or pan masala brands.
- Celebrity managers may tighten endorsement screening, raising talent costs and reducing willingness of top-tier actors to represent regulated or reputationally sensitive categories.